Submitted by Anonymous (not verified) on 29 October 2026 - 15:10
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Revision: 2, Status: Authorised